| | |
14 Dec | | Evolva
Evolva obtains patent coverage in Russia on EV-077 for use in complications of diabetes |
12 Dec | | Cytoo
CYTOO, Cenix BioScience and academic collaborators Bioquant, EPFL and FTMC receive a 4M€ EU FP7 grant to launch MEHTRICS consortium |
09 Dec | | Prosonix
Development of Multi-component Drug Particles Combining Two Respiratory Drugs |
08 Dec | | Evolva
Evolva to receive second milestone payment from Roche |
06 Dec | | CPT
Valeo acquires electric supercharger technology |
06 Dec | | Technolas Perfect Vision
Bausch + Lomb and Technolas™ Perfect Vision Announce CE Mark Approval for VICTUS™ Femtosecond Laser Platform |
09 Dec | | Sequana
NHS National Innovation Centre estimates Sequana Medical's ALFApump® System could save the NHS £50 million in ascites care annually |
21 Nov | | Cytoo
Cytoo raises 10M$ (7M€) in series C Round |
25 Oct | | Prosonix
New Scientific Advisory Board |
10 Oct | | ProtAffin
ProtAffin AG announces preclinical data in Multiple Sclerosis for MCP-1 decoy program |
27 Sept | | Prosonix
Dr Ken Cunningham elected to Board of Directors |
26 Sept | | ProtAffin
ProtAffin AG appoints Dr Mike Bartley as Chief Development Officer |
26 Sept | | Cytoo
The ETICS project, led by CYTOO in collaboration with Cellectis bioresearch and the CEA, to receive €7.6 million in aid from OSEO |
08 Sept | | Technolas Perfect Vision
Bausch + Lomb Enters Into Definitive Agreement with Technolas Perfect Vision GmbH Acquiring An Option to Purchase Company |
18 Aug | | Evolva
Evolva Coordinated Sale Process To End |
17 Aug | | inge watertechnologies
BASF announces completion of acquisition of inge watertechnologies AG |
15 Aug | | Evolva
Evolva secures financing of up to CHF 30 million |
03 Aug | | Evolva
Renowned Synthetic Biology – Metabolic Engineering
Experts Jay Keasling and Douglas Cameron Join Evolva
Scientific Advisory Board |
01 Aug | | OptiNose
OptiNose Announces Additional Leadership Team Members |
25 July | | Evolva
Positive ex vivo data on EV-077 in diabetics presented at ISTH conference in Kyoto, Japan |
25 July | | ProtAffin
ProtAffin AG strengthens Supervisory Board |
15 July | | Evolva
Evolva completes Phase I studies with EV-077 |
13 July | | Sequana Medical
Sequana Medical receives CE Mark Approval for the ALFApump™ System and adds Key Executive to Team |
29 June | | Prosonix
Prosonix Secures £11.4M Series B Financing |
23 June | | Xeros
Xeros launches new corporate video (watch video) |
14 June | | Evolva
Evolva to receive first milestone payment from Roche |
| | Mark Approval |
01 June | | NovaShunt
NovaShunt announces the launch of its new corporate identity:
Sequana Medical |
30 May | | D3O
D3O launches new corporate identity (watch video) |
26 May | | Entrepreneurs Fund
Peter Dudek joins Entrepreneurs Fund |
18 May | | Evolva
Evolva shareholders approve all Board proposals in AGM
Green light for Abunda acquisition |
17 May | | Evolva
Evolva’s major shareholders agree to continue the coordinated sale |
06 May | | Technolas Perfect Vision
Technolas Perfect Vision’s New SUPRACOR™ Presbyopia Treatment Receives CE Mark Approval |
05 May | | General Fusion
General Fusion Closes $19.5M Series B Funding Round |
26 Apr | | inge watertechnologies
BASF to acquire ultrafiltration specialist
inge watertechnologies AG |
05 Apr | | Evolva
Evolva to Acquire Abunda Nutrition |
30 Mar | | FutureE
T-Venture, Entrepreneurs Fund and KfW invest in FutureE |
28 Mar | | Evolva
FDA clears Evolva’s IND for EV-077 in influenza |
17 Mar | | Technolas Perfect Vision
Technolas Perfect Vision Showcasing New All-Laser Femtosecond Cataract and Refractive System at Major US Ophthalmology Meeting |
15 Mar | | Technolas Perfect Vision
Technolas Perfect Vision Reports Double Digit Growth in US LASIK Procedures |
14 Mar | | Technolas Perfect Vision
Technolas Perfect Vision Receives FDA Approval of Latest Technology for Custom LASIK |
14 Mar | | ProtAffin
ProtAffin AG granted patent in EU for CellJammer® discovery technology |
09 Mar | | NovaShunt
NovaShunt AG raises $25 Million in a Series B Financing Co-Led by BioMedInvest AG, Entrepreneurs Fund and Capricorn Health-tech Fund |
07 Mar | | Evolva
BASF and Evolva enter into a collaboration to develop
compounds applied to protect crops |
25 Jan | | inge watertechnologies AG
inge watertechnologies launches new range of compact ‘plug-and-work’ modules |
19 Jan | | Exosect
Exosect announces Japanese Distributor for Exosex SPTab |
| | |
| | |
| | |
| | |
| | |
| | |
